Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Adenomatous Polyposis Coli × Eicosapentaenoic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Psoriasis 1 Polyps 1 Osteoarthritis 1 Leukemia, Myeloid, Chronic-Phase 1 Hyperplasia 1 Colorectal Neoplasms 1 Cancer Cachexia 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Adenomatous Polyposis Coli 1

Interventions

Celecoxib 4 Sulindac 2 Erlotinib Hydrochloride 2 Eflornithine 2 Surveys and Questionnaires 1 Sirolimus 1 Sigmoidoscopy 1 Gastroscopy 1 Endoscopy 1 Eicosapentaenoic Acid 1 Curcumin 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed

58 enrolled 12 charts

Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡